Vertex Pharmaceuticals Heading $600? A Stock Outlook
Investors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Explore what makes the best high yield dividend ETF for retirees, focusing on yield stability, fees, and diversification. This quick intro helps you compare options.
26,985 articlesInvestors keep asking if Vertex Pharmaceuticals is headed to $600. This article breaks down the core business, pipeli...
Tether’s move to undergo a Big Four audit has crypto markets buzzing. This deep dive explains why the name of the aud...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
The waiver for Russian crude expires, ending limited relief as oil markets tighten and fuel costs threaten households...
A noted economist who studied sports money foresees a record run for FIFA, with 2026 ticket receipts pushing revenue ...
A sweeping crypto downturn sparks roughly $1.2 billion in liquidations, as Ethereum tests key support under $1.7K and...
As clean energy climbs, storage plays a pivotal role. This article breaks down why energy stock soaring today points ...
Executives from SpaceX and Charter are in early talks about a consumer mobile service that could route SpaceX phone t...
A growing number of public companies are moving beyond simply accumulating crypto. This article explains why strategy...
When a chief executive sells stock, investors ask if the move is a red flag or a routine tax-related step. This piece...
Nu Holdings is poised for a volatile after-hours session as it reports quarterly results. Analysts weigh margin gains...
Gabelli’s team signals a long-running capex wave in defense, benefiting both the big primes and smaller suppliers. Al...